Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 8 Issue 3

Structure Based Analysis of Tumor Inducing NF-κB Protein Using Phytochemical from Catharanthus Roseus Medicinal Plant

Priyanka Das, Vibha Aggrawal, Avinaash Chaurasiya and Akhileshwar Kumar Srivastava*

Department of Biotechnology, Sri Agrasen Kanya P.G. College, Bulanala, Varanasi, India

*Corresponding Author:Akhileshwar Kumar Srivastava, Department of Biotechnology, Sri Agrasen Kanya P.G. College, Bulanala, Varanasi, India.

Received: February 05, 2024; Published: February 21, 2024

Abstract

NF-κB plays important role in inflammatory response. Hence, the method of inhibiting NF-κB signaling has potential therapeutic application in cancer and inflammatory diseases. Conventional drug vinpocetine is used for treatment of cancer. The other conventional drug (vindoline, vindolinine, catharoseumine) are used for diabetes, curing hypoglycemic effects, curing hypertension and cancer too. The present study is explore vindoline, vindolinine and catharoseumine in comparison to vinpocetine by using molecular docking. The online server ‘swiss ADME analysis’ detected the physiochemical pharmacokinetics and drug likeness score and medicinal chemistry of vinpocetine and conventional drugs. Results from swiss ADME analysis showed that vinpocetine and conventional drugs did not violate the “Lipinski five rule” for drug. The resulted binding energy of vindoline, vindolinine and catharoseumine were -6.5, -8.17 and -8.6 respectively. The binding energy (-8.6 kcal/mol) of catharoseumine was higher than vinpocetine (-7.35 kcal/mol). Thus, catharoseumine has greater potential to interact with interacting residues of NF-κB further consideration as an anti cancerous regimen.

Keywords: Tumor; NF-κB Protein; Phytochemical; Catharanthus Roseus; Medicinal Plant

References

    1. Aruna Aasirvatham. “Madagascar periwinkle as natural diabetic medicine gift to mankind”. IEEE-SEM 5 (2020).
    2. M Padmaa Paarakh., et al. “Catharanthus roseus Linn-A Review”. Acta Scientific Pharmaceutical Sciences10 (2019): 19-24.
    3. Narayan Mishra and Navneet Kumar Verma. “A brief study on Catharanthus roseus: A Review”. International Journal of Research in Pharmacy and Pharmaceutical and Sciences2 (2017).
    4. Suddhasuchi Das and Amit B Sharangi. “Madagascar periwinkle (Catharanthus roseus L.): Diverse medicinal and therapeutic benefits to humankind”. Journal of Pharmacognosy and Phytochemistry3 (2017): 1695- 1710.
    5. Huang DJ., et al. “The chemistry behind antioxidant capacity assays”. Journal of Agricultural and Food Chemistry 53 (2005): 1841-1856.
    6. Monika Sain. “Biotechnological studies on Catharanthus roseus (an anti cancerous drug yielding plant) (2018).
    7. TD Gilmore and M Hercovich. “Study on inhibitors of NF-κB signaling:785 and counting”. Oncogene 51 (2006): 6887-6899.
    8. J Dutta., et al. “Current insights into the regulation of programmed cell death by NF-κB”. Oncogene 51 (2006): 6800-6816.
    9. DT Starczynowski., et al. “Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patient’s with B-cell lymphoma enhances REL’s in vitro transforming. NF-κB as a primary regulator of the stress response activity”. Oncogene19 (2007): 2685-2694.
    10. DS Basseres and AS Baldwin. “Nuclear factor-kB and inhibitor of kB kinase pathways in oncogenic initiation and progression”. Oncogene51 (2006): 6817-6830.
    11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231735/
    12. https://www.thehindu.com

    Citation

    Citation: Akhileshwar Kumar Srivastava. “Structure Based Analysis of Tumor Inducing NF-κB Protein Using Phytochemical from Catharanthus Roseus Medicinal Plant".Acta Scientific Pharmaceutical Sciences 8.3 (2024): 44-56.

    Copyright

    Copyright: © 2024 Akhileshwar Kumar Srivastava. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US